Nu-Med Plus (NUMD) Net Cash Flow Growth (5y) (2017 - 2025)
Nu-Med Plus (NUMD) Net Cash Flow Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn |
| 2 | Stryker | 127.77 Bn | 124.29 Bn | 4.50 Bn |
| 3 | Medtronic | 119.02 Bn | 109.80 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.58 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.96% |
| Sep 30, 2025 | -19.62% |
| Dec 31, 2024 | 45.52% |
| Jun 30, 2024 | 21.14% |
| Mar 31, 2024 | 68.46% |
| Dec 31, 2023 | -41.72% |
| Sep 30, 2023 | 30.94% |
| Jun 30, 2023 | -30.45% |
| Mar 31, 2023 | 23.23% |
| Dec 31, 2022 | 15.96% |
| Sep 30, 2022 | -66.36% |
| Jun 30, 2022 | 45.75% |
| Mar 31, 2022 | -15.21% |
| Dec 31, 2021 | -30.76% |
| Sep 30, 2021 | -2.38% |
| Jun 30, 2021 | -5.93% |
| Mar 31, 2021 | -23.46% |
| Dec 31, 2020 | 38.61% |
| Sep 30, 2020 | 34.61% |
| Jun 30, 2020 | -39.99% |